BUSINESS Pakistan faces a Diabetes explosion while local Pharma Companies race to produce affordable Ozempic and Mounjaro alternativesImran MalikJune 27, 2026 Pakistan tops global diabetes prevalence at 30.8% with 36 million patients, yet revolutionary GLP-1 drugs like Ozempic and Mounjaro remain…